Lucio Iannone
InvestorManaging Director at JDRF T1D Fund · Board director at Immunitas Therapeutics
Boston, Massachusetts, United States
About
Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
Board director at Immunitas Therapeutics
Intro paths
→
In turn, Lucio can intro founders to Immunitas Therapeutics's investors below.
Immunitas Therapeutics's investors · 9
Agent CapitalWaltham · since 2021DC Investment PartnersMcLean · $10M checks · since 2021Leaps by BayerLeverkusen · since 2021Longwood FundBoston · since 2021M VenturesLos Angeles · $10.8M checks · since 2021Medical Excellence CapitalNew York · since 2021Novartis Venture FundBasel · $5M – $25M checks · since 2021Ono Venture Investment, Inc.South San Francisco · since 2021Solasta VenturesBoston · since 2021
Experience
- T1D FundSr Managing Directorcurrent2025 — presentБостон, MA
- Amana Global PartnersSenior Investment Advisorcurrent2023 — present
- COUR PharmaBoard Observercurrent2025 — present
- Leaps by BayerHead of Venture Investments2021 — 2025Кембридж, MA
- Leaps by BayerSr Director of Venture Investments2017 — 2021Boston, Massachusetts
- Soufflé TherapeuticsBoard Member2023 — 2025
- Paratus SciencesBoard Member2022 — 2025Cambridge, Massachusetts, United States
- CellinoBoard Member2022 — 2025Cambridge, Massachusetts, United States
- Mozart Therapeutics, IncBoard Member2021 — 2025Seattle, Washington, United States
- Deka Biosciences, IncBoard Member2021 — 2025Germantown, Maryland, United States
- eGenesis, Inc.Board Member2019 — 2025Cambridge, Massachusetts
- Immunitas TherapeuticsBoard Member2019 — 2025Cambridge, Massachusetts
- Capstan TherapeuticsBoard Observer2023 — 2025Boston, Massachusetts, United States
- NextPoint Therapeutics, Inc.Board Observer2022 — 2025Cambridge, Massachusetts, United States
- Boundless BioBoard Observer2023 — 2025San Diego, California, United States
- Axxam S.p.ABoard Member2019 — 2022
- MetagenomiBoard Observer2020 — 2022
- Pyxis OncologyBoard Member2019 — 2021Cambridge, Massachusetts
- Silence Therapeutics plcHead of Business Development2015 — 2017London, England, United Kingdom
- Silence Therapeutics plcScientific Officer Translational Medicine2014 — 2015London
- Imperial College LondonCardiovascular Scientist2011 — 2014Londra, Regno Unito
Skills & more
Cell Biology23Biotechnology22Cell Culture9Genetics8Pharmaceutical Industry9Biochemistry6Pharmacokinetics5Lifesciences5Pharmacology4Drug development4Ricerca4Scienza4
+12 more
GeneticaIndustria farmaceuticaBiochimicaBiotecnologiaBiologia molecolareScienze naturaliIn vitroR&DABPI code of practiceReal TimeStrategiaBloombergLanguages Inglese · Italiano · Portoguese · Spanish
From Lucio's professional profile.
Colleagues at JDRF T1D Fund
Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures
Network2
Investors connected to Lucio in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Lucio Iannone?
- Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
- Where does Lucio Iannone work?
- Lucio Iannone is Managing Director at JDRF T1D Fund and Board director at Immunitas Therapeutics.
- Where did Lucio Iannone go to school?
- Lucio Iannone studied at Imperial College London (Doctor of Philosophy (Ph.D.), Medicine); Università degli Studi di Napoli Federico II (Bachelor's degree, Biotechnology).
Same school
Also attended Imperial College London598
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 592 more
Also attended Università degli Studi di Napoli Federico II24
Fabio CampanileSwitzerland Board Member at MassChallenge MexicoGiuseppe JandoliInvestment Analyst at Apex CapitalLuca QuagliataVenture Partner at XGEN VentureLuca CaralviVenture Partner at VentureWave Capital Ltd.Daniele SpadaGeneral Manager at Tages Capital SGR S.p.A.Cecilia Loro PianaInvestor at Nuova Energia Holding S.p.A.
+ 18 more
